Subscribe submit

Molecular and Cellular Therapies

Vol: 2013    Issue: 1

Published In:  January 2013

Assessment of efficacy of trastuzumab (Herceptin) comprising adjuvant therapy of HER2+ breast cancer patients determined based upon statistical analysis of overall survival (OS) and disease-free survival (PFS)

Article No: 2    Page: 1-13   

Read other article:
1 2 3 4 5 6



River Publishers: Molecular and Cellular Therapies